कृपया अन्य खोज का प्रयास करें
RegeneRx Biopharmaceuticals, Inc., a biopharmaceutical company, focuses on the development of therapeutic peptide, Thymosin beta 4, for tissue and organ protection, repair, and regeneration. The company is developing RGN-259, a preservative-free topical eye drop for regeneration of corneal tissues damaged by injury, disease, or other pathology; RGN-352, an injectable formulation for the treatment of cardiovascular diseases, central and peripheral nervous system diseases, and other medical indications; and RGN-137, a topical gel for the treatment of dermal wounds and reduction of scar tissue. It has strategic partnerships with Lee’s Pharmaceutical Group and HLB Therapeutics. The company was formerly known as Alpha 1 Biomedicals, Inc. and changed its name to RegeneRx Biopharmaceuticals, Inc. in 2000. RegeneRx Biopharmaceuticals, Inc. was incorporated in 1982 and is based in Rockville, Maryland.
नाम | आयु | पहले | शीर्षक |
---|---|---|---|
Allan L. Goldstein | 86 | 1982 | Founder, Chairman, Chief Scientific Officer & Chairman of Scientific Advisor Board |
Gabriel Sosne | - | - | Scientific Advisory Board Member |
Jo-David Fine | - | - | Scientific Advisory Board Member |
J. J. Finkelstein | 72 | 2002 | President, CEO & Director |
R. Donald Elsey | 70 | 2010 | Independent Director |
Ewald Hannappel | - | - | Scientific Advisory Board Member |
Mauro Bove | 69 | 2004 | Independent Director |
Barrett Katz | 74 | - | Scientific Advisory Board Member |
Joseph Claudius McNay | 90 | 2002 | Independent Director |
Hynda K. Kleinman | - | - | Scientific Advisory Board Member |
Deepak Srivastava | - | - | Scientific Advisory Board Member |
Alessandro Noseda | 65 | 2019 | Independent Director |
क्या आप सच में %USER_NAME% को ब्लॉक करना चाहते हैं?
ऐसा करके, आप और %USER_NAME% नहीं देख पाएंगे किसी अन्य के Investing.com की पोस्ट में से कोई भी।
%USER_NAME% को सफलतापूर्वक आपकी ब्लॉक सूची में जोड़ लिया गया है
क्योंकि आपने इस व्यक्ति को अनब्लॉक कर दिया है, आपको ब्लॉक को रिन्यू करने से पहले 48 घंटे प्रतीक्षा करनी होगी।
मुझे लगता है कि यह टिपण्णी:
धन्यवाद!
आपकी रिपोर्ट समीक्षा के लिए हमारे मॉडरेटर को भेजी गई है